In fact, comparing GLP-1 alone administration, the co-infusion resulted in similar blood glucose and insulin secretion rates in type 2 diabetes, but the suppression of plasma glucagon by GLP-1 was antagonized by GIP [118]. Here, INS is linked to type 2 diabetes mellitus.